JAE H PARK

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NEW YORK, NY NPI 1669593000

General Payments — all program years on this page

$279,972.91

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 183
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $44,716.45 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $25,792.1623
2019 $53,890.0255
2020 $50,389.0525
2021 $21,788.009
2022 $56,863.7722
2023 $26,533.4611
2024 $44,716.4538

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087345331 Novartis Pharmaceuticals Corporation $150.76 07/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087345333 Novartis Pharmaceuticals Corporation $2,362.50 07/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104408339 AstraZeneca Pharmaceuticals LP $290.70 09/30/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 View at CMS
1111670296 Amgen Inc. $686.00 04/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1111670298 Amgen Inc. $41.84 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128609733 Kite Pharma, Inc. $4,110.00 06/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1128609735 Kite Pharma, Inc. $50.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131187216 PFIZER INC. $61.92 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133599289 Gilead Sciences, Inc. $15,120.00 04/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133599291 Gilead Sciences, Inc. $4,120.00 09/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133599293 Gilead Sciences, Inc. $3,090.00 11/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133865993 Gilead Sciences, Inc. $266.80 02/12/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133865995 Gilead Sciences, Inc. $6,976.17 02/12/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133865997 Gilead Sciences, Inc. $98.13 02/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133866039 Gilead Sciences, Inc. $138.00 02/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133866417 Gilead Sciences, Inc. $291.31 02/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133866419 Gilead Sciences, Inc. $98.13 02/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133866421 Gilead Sciences, Inc. $301.25 04/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137943611 TAIHO ONCOLOGY, INC. $163.04 09/30/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 View at CMS
1147113936 Iovance Biotherapeutics, Inc. $89.02 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147113940 Iovance Biotherapeutics, Inc. $35.00 11/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147113944 Iovance Biotherapeutics, Inc. $160.60 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147113948 Iovance Biotherapeutics, Inc. $2,055.00 12/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1147113952 Iovance Biotherapeutics, Inc. $13.23 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147113956 Iovance Biotherapeutics, Inc. $14.10 12/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147113960 Iovance Biotherapeutics, Inc. $70.95 12/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147113972 Iovance Biotherapeutics, Inc. $51.29 12/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147113976 Iovance Biotherapeutics, Inc. $39.96 12/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147113988 Iovance Biotherapeutics, Inc. $58.89 12/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147113992 Iovance Biotherapeutics, Inc. $16.13 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147113996 Iovance Biotherapeutics, Inc. $19.60 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147114000 Iovance Biotherapeutics, Inc. $572.13 12/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1150226380 JAZZ PHARMACEUTICALS INC. $73.49 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150259708 Adaptive Biotechnologies Corporation $2,400.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1150262236 Adaptive Biotechnologies Corporation $131.18 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150262238 Adaptive Biotechnologies Corporation $14.58 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150264075 Adaptive Biotechnologies Corporation $475.76 07/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1150264077 Adaptive Biotechnologies Corporation $8.99 07/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.